ES2293996T3 - Compuestos antitumorales. - Google Patents
Compuestos antitumorales. Download PDFInfo
- Publication number
- ES2293996T3 ES2293996T3 ES01936649T ES01936649T ES2293996T3 ES 2293996 T3 ES2293996 T3 ES 2293996T3 ES 01936649 T ES01936649 T ES 01936649T ES 01936649 T ES01936649 T ES 01936649T ES 2293996 T3 ES2293996 T3 ES 2293996T3
- Authority
- ES
- Spain
- Prior art keywords
- sub
- substituted
- unsubstituted
- mhz
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title claims description 49
- 230000000259 anti-tumor effect Effects 0.000 title description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 34
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 34
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 33
- 125000003118 aryl group Chemical group 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 27
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 20
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 18
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 15
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 12
- 150000002367 halogens Chemical class 0.000 claims abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 36
- 125000004429 atom Chemical group 0.000 claims description 19
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 9
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- SYFQZCUQZJXUQE-UHFFFAOYSA-N 4-aminoicosan-5-ol Chemical compound CCCCCCCCCCCCCCCC(O)C(N)CCC SYFQZCUQZJXUQE-UHFFFAOYSA-N 0.000 claims description 4
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 4
- 239000001257 hydrogen Chemical group 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 4
- RCYFWNYHEBGXJX-UHFFFAOYSA-N 4-aminoicosan-5-one;hydrobromide Chemical compound Br.CCCCCCCCCCCCCCCC(=O)C(N)CCC RCYFWNYHEBGXJX-UHFFFAOYSA-N 0.000 claims description 3
- 125000004104 aryloxy group Chemical group 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005017 substituted alkenyl group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract description 3
- 125000001424 substituent group Chemical group 0.000 abstract description 2
- YRYJJIXWWQLGGV-ZWKOTPCHSA-N 1-deoxysphinganine Chemical class CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N YRYJJIXWWQLGGV-ZWKOTPCHSA-N 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 300
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 207
- 238000005160 1H NMR spectroscopy Methods 0.000 description 136
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 113
- 238000000034 method Methods 0.000 description 108
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 107
- 235000019439 ethyl acetate Nutrition 0.000 description 102
- 239000007787 solid Substances 0.000 description 95
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 58
- 150000001414 amino alcohols Chemical class 0.000 description 58
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 53
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 51
- 239000000243 solution Substances 0.000 description 44
- 239000003921 oil Substances 0.000 description 37
- 125000004432 carbon atom Chemical group C* 0.000 description 34
- 150000001299 aldehydes Chemical class 0.000 description 33
- 229910052757 nitrogen Inorganic materials 0.000 description 30
- 239000000377 silicon dioxide Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000004440 column chromatography Methods 0.000 description 24
- 238000003756 stirring Methods 0.000 description 24
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 22
- 125000001309 chloro group Chemical group Cl* 0.000 description 21
- 239000000203 mixture Substances 0.000 description 21
- 239000012230 colorless oil Substances 0.000 description 20
- 239000007832 Na2SO4 Substances 0.000 description 19
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 19
- 229910052938 sodium sulfate Inorganic materials 0.000 description 19
- 235000011152 sodium sulphate Nutrition 0.000 description 19
- -1 acid hydrochloric Chemical class 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 150000002576 ketones Chemical class 0.000 description 14
- 238000000746 purification Methods 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- JKOTZBXSNOGCIF-UHFFFAOYSA-N 1-bromopentadecane Chemical compound CCCCCCCCCCCCCCCBr JKOTZBXSNOGCIF-UHFFFAOYSA-N 0.000 description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000012267 brine Substances 0.000 description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 150000001540 azides Chemical class 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 150000003462 sulfoxides Chemical class 0.000 description 4
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical compound COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 229910010084 LiAlH4 Inorganic materials 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- 229920006362 Teflon® Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 150000002923 oximes Chemical class 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 2
- JCBPETKZIGVZRE-BYPYZUCNSA-N (2s)-2-aminobutan-1-ol Chemical compound CC[C@H](N)CO JCBPETKZIGVZRE-BYPYZUCNSA-N 0.000 description 2
- SZXBQTSZISFIAO-ZETCQYMHSA-N (2s)-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OC(C)(C)C SZXBQTSZISFIAO-ZETCQYMHSA-N 0.000 description 2
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- HHSDZLLPIXMEIU-UHFFFAOYSA-N 1-bromoheptadecane Chemical compound CCCCCCCCCCCCCCCCCBr HHSDZLLPIXMEIU-UHFFFAOYSA-N 0.000 description 2
- HNTGIJLWHDPAFN-UHFFFAOYSA-N 1-bromohexadecane Chemical compound CCCCCCCCCCCCCCCCBr HNTGIJLWHDPAFN-UHFFFAOYSA-N 0.000 description 2
- KOFZTCSTGIWCQG-UHFFFAOYSA-N 1-bromotetradecane Chemical compound CCCCCCCCCCCCCCBr KOFZTCSTGIWCQG-UHFFFAOYSA-N 0.000 description 2
- IKPSIIAXIDAQLG-UHFFFAOYSA-N 1-bromoundecane Chemical compound CCCCCCCCCCCBr IKPSIIAXIDAQLG-UHFFFAOYSA-N 0.000 description 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 description 2
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VDRZDTXJMRRVMF-UONOGXRCSA-N D-erythro-sphingosine Natural products CCCCCCCCCC=C[C@@H](O)[C@@H](N)CO VDRZDTXJMRRVMF-UONOGXRCSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 150000003410 sphingosines Chemical class 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- IEEFFKXJADVWJO-OAHLLOKOSA-N (2r)-2-(dibenzylamino)propan-1-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CO)C)CC1=CC=CC=C1 IEEFFKXJADVWJO-OAHLLOKOSA-N 0.000 description 1
- CJIILUGXXXKRTA-UNTBIKODSA-N (2r)-2-aminooctadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC(=O)[C@@H](C)N CJIILUGXXXKRTA-UNTBIKODSA-N 0.000 description 1
- AUGRPIHBMZBMKB-PPTMTGTBSA-N (2r,3s)-2-(dibenzylamino)octadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@H](C)[C@@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 AUGRPIHBMZBMKB-PPTMTGTBSA-N 0.000 description 1
- YRYJJIXWWQLGGV-MSOLQXFVSA-N (2r,3s)-2-aminooctadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@@H](C)N YRYJJIXWWQLGGV-MSOLQXFVSA-N 0.000 description 1
- LHAUQAAPXGACHN-XIFFEERXSA-N (2s)-2,5-bis(dibenzylamino)pentan-1-ol Chemical compound C([C@@H](CO)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 LHAUQAAPXGACHN-XIFFEERXSA-N 0.000 description 1
- WUAUOTVCWFISNJ-XIFFEERXSA-N (2s)-2,5-bis(dibenzylamino)pentanal Chemical compound C([C@@H](C=O)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 WUAUOTVCWFISNJ-XIFFEERXSA-N 0.000 description 1
- IEEFFKXJADVWJO-HNNXBMFYSA-N (2s)-2-(dibenzylamino)propan-1-ol Chemical compound C=1C=CC=CC=1CN([C@H](CO)C)CC1=CC=CC=C1 IEEFFKXJADVWJO-HNNXBMFYSA-N 0.000 description 1
- VJWLDAUJROTQMV-NTISSMGPSA-N (2s)-2-aminoheptadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC(=O)[C@H](C)N VJWLDAUJROTQMV-NTISSMGPSA-N 0.000 description 1
- BVYAQELNVWDOGL-FERBBOLQSA-N (2s)-2-aminononadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCCC(=O)[C@H](C)N BVYAQELNVWDOGL-FERBBOLQSA-N 0.000 description 1
- CJIILUGXXXKRTA-LMOVPXPDSA-N (2s)-2-aminooctadecan-3-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC(=O)[C@H](C)N CJIILUGXXXKRTA-LMOVPXPDSA-N 0.000 description 1
- KVTLSBYHFYBBFH-YWPUXERESA-N (2s,3r)-2-(dibenzylamino)-1-(4-phenylmethoxyphenyl)octadecan-3-ol Chemical compound C([C@@H]([C@H](O)CCCCCCCCCCCCCCC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)C(C=C1)=CC=C1OCC1=CC=CC=C1 KVTLSBYHFYBBFH-YWPUXERESA-N 0.000 description 1
- CGNUTARTEHVLRP-MSEJLTFDSA-N (2s,3r)-2-(dibenzylamino)docosan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 CGNUTARTEHVLRP-MSEJLTFDSA-N 0.000 description 1
- AMYDWPSWVLJPFG-QCENPCRXSA-N (2s,3r)-2-(dibenzylamino)heptadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCC)CC1=CC=CC=C1 AMYDWPSWVLJPFG-QCENPCRXSA-N 0.000 description 1
- ASXLWVNQVNTGME-BHBYDHKZSA-N (2s,3r)-2-(dibenzylamino)hexadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCC)CC1=CC=CC=C1 ASXLWVNQVNTGME-BHBYDHKZSA-N 0.000 description 1
- KUPBLDFJHZXYHN-AFPLUKJUSA-N (2s,3r)-2-(dibenzylamino)icosan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 KUPBLDFJHZXYHN-AFPLUKJUSA-N 0.000 description 1
- IYYPBDNIIAOFBP-BZKUTMRRSA-N (2s,3r)-2-(dibenzylamino)nonadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCC)CC1=CC=CC=C1 IYYPBDNIIAOFBP-BZKUTMRRSA-N 0.000 description 1
- BCRUPINZGODLPA-LITSAYRRSA-N (2s,3r)-2-(dibenzylamino)pentadecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCC)CC1=CC=CC=C1 BCRUPINZGODLPA-LITSAYRRSA-N 0.000 description 1
- AZEJZDXDKOWICO-LBNVMWSVSA-N (2s,3r)-2-(dibenzylamino)tetradecan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCC)CC1=CC=CC=C1 AZEJZDXDKOWICO-LBNVMWSVSA-N 0.000 description 1
- KOUDXTKPINRAPD-PIZIKKFZSA-N (2s,3r)-2-(dibenzylamino)tricosan-3-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](O)CCCCCCCCCCCCCCCCCCCC)CC1=CC=CC=C1 KOUDXTKPINRAPD-PIZIKKFZSA-N 0.000 description 1
- UIUTVIWNQMKVAC-VQTJNVASSA-N (2s,3r)-2-(dimethylamino)octadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N(C)C UIUTVIWNQMKVAC-VQTJNVASSA-N 0.000 description 1
- HLHYZTNWRJAUQR-RBUKOAKNSA-N (2s,3r)-2-(methylamino)octadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC HLHYZTNWRJAUQR-RBUKOAKNSA-N 0.000 description 1
- QZXQYPRJHXBKEW-JHOUSYSJSA-N (2s,3r)-2-amino-1-[tert-butyl(diphenyl)silyl]oxyoctadec-4-en-3-ol Chemical compound C=1C=CC=CC=1[Si](C(C)(C)C)(OC[C@H](N)[C@H](O)C=CCCCCCCCCCCCCC)C1=CC=CC=C1 QZXQYPRJHXBKEW-JHOUSYSJSA-N 0.000 description 1
- HQXBWUOEWTUFST-QZTJIDSGSA-N (2s,3r)-2-amino-1-fluorooctadec-4-en-3-ol Chemical compound CCCCCCCCCCCCCC=C[C@@H](O)[C@H](N)CF HQXBWUOEWTUFST-QZTJIDSGSA-N 0.000 description 1
- HPFJGEIDOJLMHD-QZTJIDSGSA-N (2s,3r)-2-amino-1-fluorooctadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](N)CF HPFJGEIDOJLMHD-QZTJIDSGSA-N 0.000 description 1
- CFSBBASAHRQSJI-FCHUYYIVSA-N (2s,3r)-2-aminodocosan-3-ol Chemical compound CCCCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N CFSBBASAHRQSJI-FCHUYYIVSA-N 0.000 description 1
- KAVSFDLDKOBXII-DLBZAZTESA-N (2s,3r)-2-aminoheptadecan-3-ol Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@H](C)N KAVSFDLDKOBXII-DLBZAZTESA-N 0.000 description 1
- JKSGUQAOWIPBPW-MCJVGQIASA-N (2s,3r)-2-aminoheptadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCC[C@@H](O)[C@H](C)N JKSGUQAOWIPBPW-MCJVGQIASA-N 0.000 description 1
- LBIRMZIEGPQRSM-JKSUJKDBSA-N (2s,3r)-2-aminohexadecan-3-ol Chemical compound CCCCCCCCCCCCC[C@@H](O)[C@H](C)N LBIRMZIEGPQRSM-JKSUJKDBSA-N 0.000 description 1
- MHXFHHNVWBIFAG-IDVLALEDSA-N (2s,3r)-2-aminohexadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCC[C@@H](O)[C@H](C)N MHXFHHNVWBIFAG-IDVLALEDSA-N 0.000 description 1
- GWXCLXFZVNFRGQ-VQTJNVASSA-N (2s,3r)-2-aminoicosan-3-ol Chemical compound CCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N GWXCLXFZVNFRGQ-VQTJNVASSA-N 0.000 description 1
- WTBBWNYCZKVGTB-CMXBXVFLSA-N (2s,3r)-2-aminoicosan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N WTBBWNYCZKVGTB-CMXBXVFLSA-N 0.000 description 1
- UJYQLGQRZHVYGT-RBUKOAKNSA-N (2s,3r)-2-aminononadecan-3-ol Chemical compound CCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N UJYQLGQRZHVYGT-RBUKOAKNSA-N 0.000 description 1
- LZGROQGFXAYCSW-GRTNUQQKSA-N (2s,3r)-2-aminononadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N LZGROQGFXAYCSW-GRTNUQQKSA-N 0.000 description 1
- FAYMLBSNJIKGQB-CJRXIRLBSA-N (2s,3r)-2-aminooctadecan-3-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N FAYMLBSNJIKGQB-CJRXIRLBSA-N 0.000 description 1
- VOUMNIKAZOWACU-LSDHHAIUSA-N (2s,3r)-2-aminopentadecan-3-ol Chemical compound CCCCCCCCCCCC[C@@H](O)[C@H](C)N VOUMNIKAZOWACU-LSDHHAIUSA-N 0.000 description 1
- IORTZRJPWMLSOC-XZOQPEGZSA-N (2s,3r)-2-aminotricosan-3-ol Chemical compound CCCCCCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)N IORTZRJPWMLSOC-XZOQPEGZSA-N 0.000 description 1
- GXVBCZQJOQACCC-RBUKOAKNSA-N (2s,3r)-3-methoxyoctadecan-2-amine Chemical compound CCCCCCCCCCCCCCC[C@@H](OC)[C@H](C)N GXVBCZQJOQACCC-RBUKOAKNSA-N 0.000 description 1
- PHSKLFAXXVZHNH-BZKUTMRRSA-N (2s,3r)-n,n-dibenzyl-3-methoxyoctadecan-2-amine Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](OC)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 PHSKLFAXXVZHNH-BZKUTMRRSA-N 0.000 description 1
- HGRNDPZSNAGKAL-OAMYOWMRSA-N (2s,3r)-octadecane-2,3-diamine;dihydrochloride Chemical compound Cl.Cl.CCCCCCCCCCCCCCC[C@@H](N)[C@H](C)N HGRNDPZSNAGKAL-OAMYOWMRSA-N 0.000 description 1
- YRYJJIXWWQLGGV-ROUUACIJSA-N (2s,3s)-2-aminooctadecan-3-ol Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](C)N YRYJJIXWWQLGGV-ROUUACIJSA-N 0.000 description 1
- XRGAOSVVLNRLHU-ROUUACIJSA-N (2s,3s)-3-chlorooctadecan-2-amine Chemical compound CCCCCCCCCCCCCCC[C@H](Cl)[C@H](C)N XRGAOSVVLNRLHU-ROUUACIJSA-N 0.000 description 1
- YYNGDOQMKFCVKA-NYDCQLBNSA-N (2s,3s)-n,n-dibenzyl-3-chlorooctadecan-2-amine Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@@H](Cl)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 YYNGDOQMKFCVKA-NYDCQLBNSA-N 0.000 description 1
- HGRNDPZSNAGKAL-MPGISEFESA-N (2s,3s)-octadecane-2,3-diamine;dihydrochloride Chemical compound Cl.Cl.CCCCCCCCCCCCCCC[C@H](N)[C@H](C)N HGRNDPZSNAGKAL-MPGISEFESA-N 0.000 description 1
- 239000001618 (3R)-3-methylpentan-1-ol Substances 0.000 description 1
- XSZHJVANGCLUFN-FERBBOLQSA-N (3s)-3-aminononadecan-4-one;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC(=O)[C@@H](N)CC XSZHJVANGCLUFN-FERBBOLQSA-N 0.000 description 1
- MXXLHTITYYVJHU-NOCHOARKSA-N (3s,4r)-3-(dibenzylamino)-2-methylnonadecan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](C(C)C)[C@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 MXXLHTITYYVJHU-NOCHOARKSA-N 0.000 description 1
- HLJJMLAPCTXGLG-SZAHLOSFSA-N (3s,4r)-3-(dibenzylamino)icosan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CC)[C@H](O)CCCCCCCCCCCCCCCC)CC1=CC=CC=C1 HLJJMLAPCTXGLG-SZAHLOSFSA-N 0.000 description 1
- GOCTYZBUNUKUFQ-JHOUSYSJSA-N (3s,4r)-3-(dibenzylamino)nonadecan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CC)[C@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 GOCTYZBUNUKUFQ-JHOUSYSJSA-N 0.000 description 1
- HRGLQWXSKJTKIJ-AJQTZOPKSA-N (3s,4r)-3-(dibenzylamino)octadecan-4-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CC)[C@H](O)CCCCCCCCCCCCCC)CC1=CC=CC=C1 HRGLQWXSKJTKIJ-AJQTZOPKSA-N 0.000 description 1
- VVCPIYXWLZVSBR-UXHICEINSA-N (3s,4r)-3-amino-2-methylnonadecan-4-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)C(C)C VVCPIYXWLZVSBR-UXHICEINSA-N 0.000 description 1
- VQNVWFLKOKFHHQ-FDOHDBATSA-N (3s,4r)-3-amino-2-methylnonadecan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)C(C)C VQNVWFLKOKFHHQ-FDOHDBATSA-N 0.000 description 1
- YHDSKQMWOBVXCK-VQTJNVASSA-N (3s,4r)-3-aminoicosan-4-ol Chemical compound CCCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC YHDSKQMWOBVXCK-VQTJNVASSA-N 0.000 description 1
- HCLFEEHNUHFUFS-CMXBXVFLSA-N (3s,4r)-3-aminoicosan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC HCLFEEHNUHFUFS-CMXBXVFLSA-N 0.000 description 1
- LBMMFFUIESTUET-RBUKOAKNSA-N (3s,4r)-3-aminononadecan-4-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC LBMMFFUIESTUET-RBUKOAKNSA-N 0.000 description 1
- BYRQRAPUQDAMQM-GRTNUQQKSA-N (3s,4r)-3-aminononadecan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC BYRQRAPUQDAMQM-GRTNUQQKSA-N 0.000 description 1
- XKMUUIRZUAXHDT-ZWKOTPCHSA-N (3s,4r)-3-aminooctadecan-4-ol Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC XKMUUIRZUAXHDT-ZWKOTPCHSA-N 0.000 description 1
- IGWJJOINJMHRBX-CJRXIRLBSA-N (3s,4r)-3-aminooctadecan-4-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC IGWJJOINJMHRBX-CJRXIRLBSA-N 0.000 description 1
- LBMMFFUIESTUET-OALUTQOASA-N (3s,4s)-3-aminononadecan-4-ol Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CC LBMMFFUIESTUET-OALUTQOASA-N 0.000 description 1
- LVOOZEPWURRJNZ-MYZAEBQFSA-N (3s,4s,5r)-4-(dibenzylamino)-3-methylicosan-5-ol Chemical compound C=1C=CC=CC=1CN([C@@H]([C@@H](C)CC)[C@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 LVOOZEPWURRJNZ-MYZAEBQFSA-N 0.000 description 1
- ITESBDDCOKJEON-HBMCJLEFSA-N (3s,4s,5r)-4-amino-3-methylicosan-5-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)[C@@H](C)CC ITESBDDCOKJEON-HBMCJLEFSA-N 0.000 description 1
- LDKKSOGAGPATOF-NFQNBQCWSA-N (3s,4s,5r)-4-amino-3-methylicosan-5-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)[C@@H](C)CC LDKKSOGAGPATOF-NFQNBQCWSA-N 0.000 description 1
- XHBYXJQGBOESGC-JYHRMSDVSA-N (4s,5r)-1,4-bis(dibenzylamino)icosan-5-ol Chemical compound C([C@@H]([C@H](O)CCCCCCCCCCCCCCC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 XHBYXJQGBOESGC-JYHRMSDVSA-N 0.000 description 1
- WNYPMOAMZYEYQQ-VQTJNVASSA-N (4s,5r)-1,4-diaminoicosan-5-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CCCN WNYPMOAMZYEYQQ-VQTJNVASSA-N 0.000 description 1
- FHLMQUKIPXBIOJ-HUQPAIQZSA-N (4s,5r)-1,4-diaminoicosan-5-ol;dihydrochloride Chemical compound Cl.Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CCCN FHLMQUKIPXBIOJ-HUQPAIQZSA-N 0.000 description 1
- MJRCXRGIFFFXRP-SZAHLOSFSA-N (4s,5r)-4-(dibenzylamino)icosan-5-ol Chemical compound C=1C=CC=CC=1CN([C@@H](CCC)[C@H](O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 MJRCXRGIFFFXRP-SZAHLOSFSA-N 0.000 description 1
- SYFQZCUQZJXUQE-VQTJNVASSA-N (4s,5r)-4-aminoicosan-5-ol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CCC SYFQZCUQZJXUQE-VQTJNVASSA-N 0.000 description 1
- UITJBVDUQMDHTE-CMXBXVFLSA-N (4s,5r)-4-aminoicosan-5-ol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CCC UITJBVDUQMDHTE-CMXBXVFLSA-N 0.000 description 1
- YGFQERDVWZDGKR-ZWKOTPCHSA-N (4s,5r)-4-methyl-5-pentadecyl-1,3-oxazolidin-2-one Chemical compound CCCCCCCCCCCCCCC[C@H]1OC(=O)N[C@H]1C YGFQERDVWZDGKR-ZWKOTPCHSA-N 0.000 description 1
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 description 1
- WSULSMOGMLRGKU-UHFFFAOYSA-N 1-bromooctadecane Chemical compound CCCCCCCCCCCCCCCCCCBr WSULSMOGMLRGKU-UHFFFAOYSA-N 0.000 description 1
- BFDNZQUBFCYTIC-UHFFFAOYSA-N 1-bromotridecane Chemical compound CCCCCCCCCCCCCBr BFDNZQUBFCYTIC-UHFFFAOYSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N 1-butanol Substances CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- HNOAUFBMSISHIO-KRWDZBQOSA-N 1-deoxy-3-dehydrosphinganine Chemical compound CCCCCCCCCCCCCCCC(=O)[C@H](C)N HNOAUFBMSISHIO-KRWDZBQOSA-N 0.000 description 1
- WMUMHAZHWIUBPN-UONOGXRCSA-N 1-deoxytetradecasphinganine Chemical compound CCCCCCCCCCC[C@@H](O)[C@H](C)N WMUMHAZHWIUBPN-UONOGXRCSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N 1-propanol Substances CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ZPPANEJYFOVYGD-RBUKOAKNSA-N 2,2,2-trifluoro-n-[(2s,3r)-3-hydroxynonadecan-2-yl]acetamide Chemical compound CCCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(=O)C(F)(F)F ZPPANEJYFOVYGD-RBUKOAKNSA-N 0.000 description 1
- RZEBFQUQWLEGQB-ZWKOTPCHSA-N 2,2,2-trifluoro-n-[(2s,3r)-3-hydroxyoctadecan-2-yl]acetamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(=O)C(F)(F)F RZEBFQUQWLEGQB-ZWKOTPCHSA-N 0.000 description 1
- BXRVOOQRCRWPPF-UHFFFAOYSA-N 2-[5-(benzylamino)icosan-4-ylcarbamoyl]benzoic acid Chemical compound C=1C=CC=C(C(O)=O)C=1C(=O)NC(CCC)C(CCCCCCCCCCCCCCC)NCC1=CC=CC=C1 BXRVOOQRCRWPPF-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- QMJQSFDECLZDKQ-BJKOFHAPSA-N 4-[(2s,3r)-2-amino-3-hydroxyoctadecyl]phenol Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC1=CC=C(O)C=C1 QMJQSFDECLZDKQ-BJKOFHAPSA-N 0.000 description 1
- OJEXGSVEJWYOTI-KZDWWKKTSA-N 4-[(2s,3r)-2-amino-3-hydroxyoctadecyl]phenol;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CC1=CC=C(O)C=C1 OJEXGSVEJWYOTI-KZDWWKKTSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- CLYLHOQDLLERBH-URBRKQAFSA-N CCCCCCCCCCCCCCC[C@H]([C@H](CC(C(F)(F)F)=O)ON)O.OC(C(F)(F)F)=O Chemical compound CCCCCCCCCCCCCCC[C@H]([C@H](CC(C(F)(F)F)=O)ON)O.OC(C(F)(F)F)=O CLYLHOQDLLERBH-URBRKQAFSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 125000000030 D-alanine group Chemical class [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
- 238000006021 Dakin-West synthesis reaction Methods 0.000 description 1
- 244000089409 Erythrina poeppigiana Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 208000008839 Kidney Neoplasms Diseases 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- 229910003251 Na K Inorganic materials 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000009776 Rathbunia alamosensis Nutrition 0.000 description 1
- 206010038389 Renal cancer Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 229910004161 SiNa Inorganic materials 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000237543 Spisula Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- BYXJPMAYVVLAHT-BFGHFXMOSA-N [(2s,3r)-2-(dibenzylamino)octadecan-3-yl] acetate Chemical compound C=1C=CC=CC=1CN([C@@H](C)[C@H](OC(C)=O)CCCCCCCCCCCCCCC)CC1=CC=CC=C1 BYXJPMAYVVLAHT-BFGHFXMOSA-N 0.000 description 1
- GIIJVODZLVLEGD-JTHBVZDNSA-N [(2s,3r)-2-[(2-methylpropan-2-yl)oxycarbonylamino]octadecan-3-yl] acetate Chemical compound CCCCCCCCCCCCCCC[C@@H](OC(C)=O)[C@H](C)NC(=O)OC(C)(C)C GIIJVODZLVLEGD-JTHBVZDNSA-N 0.000 description 1
- OQZBKGZOQMOBSO-VKLKMBQZSA-N [(2s,3r)-2-aminooctadecan-3-yl] acetate;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCC[C@H]([C@H](C)N)OC(C)=O OQZBKGZOQMOBSO-VKLKMBQZSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- SBWYBQRWDXWJDV-NSHDSACASA-N benzyl n-[(2s)-1-hydroxybutan-2-yl]carbamate Chemical compound CC[C@@H](CO)NC(=O)OCC1=CC=CC=C1 SBWYBQRWDXWJDV-NSHDSACASA-N 0.000 description 1
- AFPHMHSLDRPUSM-VIFPVBQESA-N benzyl n-[(2s)-1-hydroxypropan-2-yl]carbamate Chemical compound OC[C@H](C)NC(=O)OCC1=CC=CC=C1 AFPHMHSLDRPUSM-VIFPVBQESA-N 0.000 description 1
- XTXJPZGMVKIPHE-VIFPVBQESA-N benzyl n-[(2s)-1-oxopropan-2-yl]carbamate Chemical compound O=C[C@H](C)NC(=O)OCC1=CC=CC=C1 XTXJPZGMVKIPHE-VIFPVBQESA-N 0.000 description 1
- DEUQDTOHXOPYNC-ZCYQVOJMSA-N benzyl n-[(2s,3s)-3-hydroxyoctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](C)NC(=O)OCC1=CC=CC=C1 DEUQDTOHXOPYNC-ZCYQVOJMSA-N 0.000 description 1
- ACAVESYJEZZZBO-UIOOFZCWSA-N benzyl n-[(3s,4s)-4-hydroxynonadecan-3-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](CC)NC(=O)OCC1=CC=CC=C1 ACAVESYJEZZZBO-UIOOFZCWSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CNWSQCLBDWYLAN-UHFFFAOYSA-N butylurea Chemical compound CCCCNC(N)=O CNWSQCLBDWYLAN-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 125000000332 coumarinyl group Chemical group O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 201000010982 kidney cancer Diseases 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- FJBVHQWKWFCOIJ-OAHLLOKOSA-N methyl (2r)-2-(dibenzylamino)propanoate Chemical compound C=1C=CC=CC=1CN([C@H](C)C(=O)OC)CC1=CC=CC=C1 FJBVHQWKWFCOIJ-OAHLLOKOSA-N 0.000 description 1
- DWKPPFQULDPWHX-GSVOUGTGSA-N methyl (2r)-2-aminopropanoate Chemical compound COC(=O)[C@@H](C)N DWKPPFQULDPWHX-GSVOUGTGSA-N 0.000 description 1
- AZGMGUYPTZUDQG-XIFFEERXSA-N methyl (2s)-2,5-bis(dibenzylamino)pentanoate Chemical compound C([C@@H](C(=O)OC)N(CC=1C=CC=CC=1)CC=1C=CC=CC=1)CCN(CC=1C=CC=CC=1)CC1=CC=CC=C1 AZGMGUYPTZUDQG-XIFFEERXSA-N 0.000 description 1
- AXAVQPASFYJDEM-YFKPBYRVSA-N methyl (2s)-2,5-diaminopentanoate Chemical compound COC(=O)[C@@H](N)CCCN AXAVQPASFYJDEM-YFKPBYRVSA-N 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- WDKILEMZUUOOCY-AZUAARDMSA-N n-[(2s,3r)-3-hydroxyoctadecan-2-yl]acetamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(C)=O WDKILEMZUUOOCY-AZUAARDMSA-N 0.000 description 1
- TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- WMYNHKOXVHXIGA-RTWAWAEBSA-N tert-butyl N-[(4S,5R)-1,1,1-trifluoro-5-hydroxy-2-oxoicosan-4-yl]oxycarbamate Chemical compound C(C)(C)(C)OC(=O)NO[C@@H](CC(C(F)(F)F)=O)[C@@H](CCCCCCCCCCCCCCC)O WMYNHKOXVHXIGA-RTWAWAEBSA-N 0.000 description 1
- QCAKWVLMNAWRQB-HXUWFJFHSA-N tert-butyl n-[(2r)-3-oxooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCCC(=O)[C@@H](C)NC(=O)OC(C)(C)C QCAKWVLMNAWRQB-HXUWFJFHSA-N 0.000 description 1
- KWSHECYEOCFPKT-IBGZPJMESA-N tert-butyl n-[(2s)-3-oxoheptadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC(=O)[C@H](C)NC(=O)OC(C)(C)C KWSHECYEOCFPKT-IBGZPJMESA-N 0.000 description 1
- XYDOOIXHMORPDI-NRFANRHFSA-N tert-butyl n-[(2s)-3-oxononadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCCCC(=O)[C@H](C)NC(=O)OC(C)(C)C XYDOOIXHMORPDI-NRFANRHFSA-N 0.000 description 1
- QCAKWVLMNAWRQB-FQEVSTJZSA-N tert-butyl n-[(2s)-3-oxooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCCC(=O)[C@H](C)NC(=O)OC(C)(C)C QCAKWVLMNAWRQB-FQEVSTJZSA-N 0.000 description 1
- ROXXCXTYCKNKSQ-LEWJYISDSA-N tert-butyl n-[(2s,3r)-3-aminooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@@H](N)[C@H](C)NC(=O)OC(C)(C)C ROXXCXTYCKNKSQ-LEWJYISDSA-N 0.000 description 1
- COGNMBADMVOOPJ-LEWJYISDSA-N tert-butyl n-[(2s,3r)-3-azidooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@@H](N=[N+]=[N-])[C@H](C)NC(=O)OC(C)(C)C COGNMBADMVOOPJ-LEWJYISDSA-N 0.000 description 1
- GHCSSUVLZCQDRS-LEWJYISDSA-N tert-butyl n-[(2s,3r)-3-hydroxyoctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](C)NC(=O)OC(C)(C)C GHCSSUVLZCQDRS-LEWJYISDSA-N 0.000 description 1
- ROXXCXTYCKNKSQ-SFTDATJTSA-N tert-butyl n-[(2s,3s)-3-aminooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](N)[C@H](C)NC(=O)OC(C)(C)C ROXXCXTYCKNKSQ-SFTDATJTSA-N 0.000 description 1
- COGNMBADMVOOPJ-SFTDATJTSA-N tert-butyl n-[(2s,3s)-3-azidooctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](N=[N+]=[N-])[C@H](C)NC(=O)OC(C)(C)C COGNMBADMVOOPJ-SFTDATJTSA-N 0.000 description 1
- GHCSSUVLZCQDRS-SFTDATJTSA-N tert-butyl n-[(2s,3s)-3-hydroxyoctadecan-2-yl]carbamate Chemical compound CCCCCCCCCCCCCCC[C@H](O)[C@H](C)NC(=O)OC(C)(C)C GHCSSUVLZCQDRS-SFTDATJTSA-N 0.000 description 1
- QLERQMHCZMGTNX-NRFANRHFSA-N tert-butyl n-[(3s)-4-oxononadecan-3-yl]carbamate Chemical compound CCCCCCCCCCCCCCCC(=O)[C@H](CC)NC(=O)OC(C)(C)C QLERQMHCZMGTNX-NRFANRHFSA-N 0.000 description 1
- MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/15—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/52—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/04—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated
- C07C225/06—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and acyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/38—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Plant Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0013783 | 2000-06-06 | ||
| GB0013783A GB0013783D0 (en) | 2000-06-06 | 2000-06-06 | New antitumoral derivatives of spisulosine-285 |
| GB0102472 | 2001-01-31 | ||
| GB0102472A GB0102472D0 (en) | 2001-01-31 | 2001-01-31 | New antitumoral derivatives of spisulosine-285 |
| GB0104732A GB0104732D0 (en) | 2001-02-26 | 2001-02-26 | New antitumoral derivatives of spisulosine-285 |
| GB0104732 | 2001-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2293996T3 true ES2293996T3 (es) | 2008-04-01 |
Family
ID=27255753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01936649T Expired - Lifetime ES2293996T3 (es) | 2000-06-06 | 2001-06-06 | Compuestos antitumorales. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7138547B2 (enExample) |
| EP (1) | EP1287006B1 (enExample) |
| JP (1) | JP2003535868A (enExample) |
| AT (1) | ATE376552T1 (enExample) |
| AU (2) | AU6251801A (enExample) |
| BR (1) | BR0111505A (enExample) |
| CA (1) | CA2410409A1 (enExample) |
| DE (1) | DE60131076T2 (enExample) |
| ES (1) | ES2293996T3 (enExample) |
| IL (2) | IL153096A0 (enExample) |
| MX (1) | MXPA02012121A (enExample) |
| WO (1) | WO2001094357A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003005965A2 (en) * | 2001-07-11 | 2003-01-23 | Musc Foundation For Research Development | Modulators of ceramidase and methods of use based thereon |
| FR2847473B1 (fr) * | 2002-11-25 | 2007-06-29 | Expanscience Lab | Composition comprenant au moins une oxazolidinone, son utilisation cosmetique et comme medicament |
| US7960589B2 (en) * | 2006-09-06 | 2011-06-14 | Emory University | Synthesis of sphingosines and their derivatives |
| US8431733B2 (en) * | 2008-03-12 | 2013-04-30 | Virobay, Inc. | Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives |
| WO2014118556A2 (en) * | 2013-01-31 | 2014-08-07 | Research Foundation Of The City University Of New York | Selective inhibitors and allosteric activators of sphingosine kinase |
| JP6661192B2 (ja) * | 2016-01-19 | 2020-03-11 | 国立大学法人北海道大学 | Sms2阻害活性を有するセラミド誘導体 |
| JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB546383A (en) * | 1940-10-08 | 1942-07-10 | Frank Lodge | New wool dyestuffs |
| US2399118A (en) | 1942-02-13 | 1946-04-23 | Mallinckrodt Chemical Works | 2-oxazolidone compounds and method for preparing the same |
| US2363082A (en) * | 1943-01-20 | 1944-11-21 | Novocol Chemical Mfg Co Inc | Anesthetic compounds, intermediates, and processes therefor |
| US2424311A (en) * | 1943-11-10 | 1947-07-22 | Merck & Co Inc | Process for making esters of 7,8-diamino nonoic acid |
| DE828547C (de) * | 1949-08-21 | 1952-01-17 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von Komplexsalzbildnern |
| GB1057651A (en) * | 1963-01-16 | 1967-02-08 | Merck & Co Inc | Chlorinated amino acids and their preparation |
| GB1433920A (en) | 1973-10-01 | 1976-04-28 | Ici Ltd | Alkanolamine derivatives |
| US6800661B1 (en) * | 1997-04-15 | 2004-10-05 | Board Of Trustees Of The University Of Illinois | Spisulosine compounds |
| US6107520A (en) * | 1997-04-15 | 2000-08-22 | The Board Of Trustees Of The University Of Illinois | Spisulosine compounds |
| US6756504B2 (en) * | 2000-04-19 | 2004-06-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Sphingolipids |
| EP1363643A2 (en) * | 2000-12-22 | 2003-11-26 | Medlyte, Inc. | Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| JP3692492B2 (ja) * | 2001-05-01 | 2005-09-07 | 独立行政法人科学技術振興機構 | 新規なスフィンゴ脂質合成阻害剤 |
| WO2003045928A1 (en) * | 2001-11-26 | 2003-06-05 | Genzyme Corporation | Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors |
| BR0205172A (pt) * | 2001-12-20 | 2004-06-29 | Cosmoferm Bv | Processo para a sìntese de esfingosina |
-
2001
- 2001-06-06 CA CA002410409A patent/CA2410409A1/en not_active Abandoned
- 2001-06-06 EP EP01936649A patent/EP1287006B1/en not_active Expired - Lifetime
- 2001-06-06 AT AT01936649T patent/ATE376552T1/de not_active IP Right Cessation
- 2001-06-06 ES ES01936649T patent/ES2293996T3/es not_active Expired - Lifetime
- 2001-06-06 BR BR0111505-7A patent/BR0111505A/pt not_active IP Right Cessation
- 2001-06-06 AU AU6251801A patent/AU6251801A/xx active Pending
- 2001-06-06 MX MXPA02012121A patent/MXPA02012121A/es active IP Right Grant
- 2001-06-06 DE DE60131076T patent/DE60131076T2/de not_active Expired - Lifetime
- 2001-06-06 IL IL15309601A patent/IL153096A0/xx unknown
- 2001-06-06 JP JP2002501905A patent/JP2003535868A/ja active Pending
- 2001-06-06 US US10/297,352 patent/US7138547B2/en not_active Expired - Fee Related
- 2001-06-06 AU AU2001262518A patent/AU2001262518B2/en not_active Ceased
- 2001-06-06 WO PCT/GB2001/002487 patent/WO2001094357A1/en not_active Ceased
-
2002
- 2002-11-26 IL IL153096A patent/IL153096A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1287006A1 (en) | 2003-03-05 |
| DE60131076D1 (de) | 2007-12-06 |
| ATE376552T1 (de) | 2007-11-15 |
| WO2001094357A1 (en) | 2001-12-13 |
| BR0111505A (pt) | 2003-06-24 |
| IL153096A (en) | 2007-09-20 |
| AU6251801A (en) | 2001-12-17 |
| EP1287006B1 (en) | 2007-10-24 |
| CA2410409A1 (en) | 2001-12-13 |
| AU2001262518B2 (en) | 2006-10-26 |
| DE60131076T2 (de) | 2008-07-31 |
| MXPA02012121A (es) | 2003-06-06 |
| IL153096A0 (en) | 2003-06-24 |
| JP2003535868A (ja) | 2003-12-02 |
| US7138547B2 (en) | 2006-11-21 |
| US20040048834A1 (en) | 2004-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Herold | Synthesis of d‐erythro‐and d‐threo‐sphingosine derivatives from l‐serine | |
| US7851651B2 (en) | Asymmetric synthesis of (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid | |
| JP4441677B2 (ja) | アミノ酸誘導体 | |
| ES2293996T3 (es) | Compuestos antitumorales. | |
| ES2369520T3 (es) | Compuesto amínico y su uso para propósitos médicos. | |
| ES2604766T3 (es) | Derivado de dolastatina-10, procedimiento de producción del mismo y composición de fármaco anticanceroso que contiene el mismo | |
| PT804410E (pt) | Metodo para a preparacao de intermediarios de inibidores da protease retroviral | |
| AU2001262518A1 (en) | Antitumoral compounds | |
| JP4282981B2 (ja) | スフィンゴシンの合成方法 | |
| EP2751124B1 (en) | Versatile and stereospecific synthesis of gamma,delta -unsaturated amino acids by wittig reaction | |
| CN104220433A (zh) | 用于制备γ氨基酸的方法和用于所述方法的中间体 | |
| EP2072505A2 (en) | A process for the preparation of oxazolidinone derivatives | |
| JP4084855B2 (ja) | 環式化合物の製法 | |
| KR100446104B1 (ko) | N-치환된카바모일기를포함하는신규한썰파메이트화합물과이의제조방법 | |
| ES2631983T3 (es) | Método de fabricación de compuestos de feniletilamina | |
| WO2025033387A1 (ja) | 糖脂質誘導体の製造法及びそれらの合成中間体並びにその結晶体 | |
| KR0150289B1 (ko) | 이미도 디카보네이트기를 포함하는 신규한 카바메이트 화합물 및 이의 제조방법 | |
| WO2011011865A1 (en) | Anticancer agents based on amino acid derivatives | |
| KR20050011310A (ko) | 광학적으로 순수한 2-아미노-1,3-디올 또는 2-아미노-3-올유도체의 제조방법 |